Human Immunology News 5.36 September 12, 2017 | |
| |
TOP STORYStatic and Dynamic DNA Loops Form AP-1-Bound Activation Hubs during Macrophage Development To better understand the mechanisms underlying context-specific 3D chromatin structure and transcription during cellular differentiation, scientists generated comprehensive in situ Hi-C maps of DNA loops in human monocytes and differentiated macrophages. [Mol Cell] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)An Aberrant NOTCH2-BCR Signaling Axis in B Cells from Patients with Chronic GvHD Investigators examined B cell receptor (BCR)-NOTCH2 synergy, since Notch has been shown to increase BCR responsiveness in normal mouse B cells. They conducted ex vivo activation and signaling assays of 30 primary samples from HCT patients with and without chronic graft-versus-host disease (GvHD). [Blood] Abstract Integrin-Assisted T-Cell Activation on Nanostructured Hydrogels The authors studied the influence of integrin-mediated cell-adhesion on T-cell activation, proliferation, and differentiation using nanostructured surfaces, which provided a well-defined system at the nanoscale compared with standard cultures. [Nano Lett] Abstract Scientists evaluated the role TIGIT checkpoint plays in the development and progression of gastric cancer (GC). They showed that the percentage of CD8 T cells that are TIGIT+ was increased in GC patients compared to healthy individuals. [Cancer Res] Abstract | Full Article Researchers showed that tumor necrosis factor receptor superfamily (TNFRSF) signaling plays a crucial role in the development and maintenance of effector regulatory T (eTreg) cells. TNFRSF signaling activated the NF-κB transcription factor RelA, which was required to maintain eTreg cells in lymphoid and non-lymphoid tissues, including RORγt+ Treg cells in the small intestine. [Cell Rep] Full Article | Graphical Abstract Scientists used an anti-CD16 monoclonal antibody and irradiated autologous peripheral blood mononuclear cells to provide a suitable environment for the natural killer (NK) cell expansion. This method more potently expanded NK cells, and the final product was composed of highly purified NK cells with less T-cell contamination. [Sci Rep] Full Article Modulation of γδ T Cell Activation by Neutrophil Elastase The authors investigated the role of neutrophils during the activation of human blood γδ T cells through CD3 molecules. They found that the up-regulation of CD69 expression, and the production of IFN-γ and TNF-α induced by anti-CD3 antibodies were potentiated by neutrophils. [Immunology] Abstract Investigators determined the role of the apoptotic endonuclease EndoG in alternative splicing of human telomerase reverse transcriptase (hTERT) and telomerase activity. A strong correlation was identified between EndoG expression levels and hTERT splice variants in human CD4+ and CD8+ T lymphocytes. [Eur J Cell Biol] Abstract Functional Characterization of T-Cells from Palatine Tonsils in Patients with Chronic Tonsillitis Researchers examined the functional status of human tonsillar T-cells in chronic tonsillitis and compared it to the acute inflammatory setting of a peritonsillar abscess. [PLoS One] Full Article Hours after injection of AS01-adjuvanted vaccine, resident cells, such as NK cells and CD8+ T cells, released IFNγ in the lymph node draining the injection site. This effect resulted from 3-O-desacyl-4’-monophosphoryl lipid A and QS-21 synergy and was controlled by macrophages, IL-12 and IL-18. [npj Vaccines] Full Article Subscribe to our sister publications: Immunology of Infectious Disease News & Immune Regulation News. | |
| |
REVIEWSChimeric Antigen Receptor (CAR)-Transduced Natural Killer Cells in Tumor Immunotherapy T cells genetically modified with a CAR have demonstrated remarkable success in the treatment of hematological cancers. Compared to T cells, CAR-transduced natural killer cells exhibit several advantages, such as safety in clinical use, the mechanisms by which they recognize cancer cells, and their abundance in clinical samples. [Acta Pharmacol Sin] Full Article Visit our reviews page to see a complete list of reviews in the human immunology research field. | |
| |
SCIENCE NEWSLycera Presents Encouraging Safety Results from Phase I ARGON Study of LYC-55716 Lycera Corp. announced the first presentation of clinical findings from the initial three cohorts of patients in Lycera’s Phase I/IIa ARGON study of its novel immuno-oncology therapeutic candidate, RORgamma agonist LYC-55716. [Press release from Lycera Corp. discussing research presented at the 2017 European Society for Medical Oncology (ESMO) Congress, Madrid] Press Release | |
| |
INDUSTRY NEWSAbCellera Launches Antibody Discovery Collaboration with GSK AbCellera Biologics, Inc. announced that it has entered into an antibody discovery research collaboration with GSK, whereby AbCellera will apply its high-throughput single-cell antibody screening platform to identify antibodies against an undisclosed membrane protein target. [AbCellera Biologics, Inc. (Business Wire, Inc.)] Press Release Aurigene Discovery Technologies Limited announced plans to initiate a Phase II trial of CA-170, a PDL1-VISTA inhibitor to be conducted at sites in India. [Aurigene Discovery Technologies Limited] Press Release | |
| |
POLICY NEWSCongress Rejects Trump Proposals to Cut Health Research Funds Congress has not only rejected the president’s National Institutes of Health proposal; lawmakers from both parties have joined forces to increase spending on biomedical research — and have bragged about it. [The New York Times] Editorial Pall Hangs over U.S.-Iran Science Ties Rising tensions between the U.S. and Iranian governments have frozen most scientific contacts between the two nations, experts reported at a forum. [ScienceInsider] Editorial Italian Scientists Welcome Surprise €400 Million Boost for Basic Research Italian scientists received a welcome surprise when Valeria Fedeli, the minister for education, university, and research, announced that Italy will put an extra €400 million into its main basic science fund, the Research Projects of National Interest (PRIN). The money, to be spent over 3 years, will more than quadruple PRIN’s annual funding. [ScienceInsider] Editorial
| |
EVENTSNEW Cell-Weizmann Institute of Science Symposium: Next Gen Immunology Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Research Technologist – Immunotherapy (STEMCELL Technologies Inc.) NEW Scientist – Immunology (STEMCELL Technologies Inc.) NEW Postdoctoral Researcher – Development of Immune System (Lund University) Postdoctoral Research Scientist – Immunogenomics (University of Oxford) Research Fellow – Mucosal Immunology (Malaghan Institute of Medical Research) Postdoctoral Fellow – Immunology Cell Based Assay (Turnstone Biologics Inc.) Postdoctoral Scholar – Regulation of Immune Responses (University of Iowa) Postdoctoral Fellowships – Immune Signaling and Metabolism (St. Jude Children’s Research Hospital) Postdoctoral Research Fellow – Immunology (Harvard Medical School, Joslin Diabetes Center) Postdoctoral Researcher – Inflammatory Diseases (University of Pennsylvania) Assistant Professor – Cell Science (University of Manitoba) Postdoctoral Position – Molecular Biology and Immunology (Harvard Medical School) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Human Immunology News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|